Molnupiravir News: Read Latest News & Live Updates on Molnupiravir, Photos, Videos at CNBCTV18.com

homeMolnupiravir News

Molnupiravir NEWS

All

healthcare | Mar 28, 2022 1:07 PM IST
Don’t see opportunity for Paxlovid in EMs; no visibility on market size for Molnupiravir: Laurus Labs
healthcare | Mar 22, 2022 3:25 PM IST
Pfizer to share technology for COVID-19 antiviral drug, Paxlovid
market | Feb 11, 2022 12:41 PM IST
Divi's Labs Q3 Earnings: Profit jumps 92% to Rs 902 crore, beats Street estimates
healthcare | Jan 30, 2022 3:52 PM IST
2 years on, vaccines, following protocols remain most effective weapons against COVID-19
business | Jan 7, 2022 9:03 AM IST
Lupin launches Molnupiravir under brand 'Molnulup' for COVID treatment
healthcare | Jan 7, 2022 7:59 AM IST
How did Molnupiravir become a part of COVID treatment globally? Details here
healthcare | Jan 5, 2022 11:20 PM IST
COVID antiviral drug Molnupiravir has major safety concerns: ICMR chief
healthcare | Jan 4, 2022 6:48 PM IST
Dr Reddy's to launch Molflu at Rs 35 per capsule for COVID treatment
healthcare | Jan 4, 2022 6:32 PM IST
As COVID-19 antiviral Molnupiravir launches in India; here's all you need to know about the pill
market | Dec 29, 2021 2:50 PM IST
Sun Pharma, Dr Reddy's, Divi's, other pharma stocks in high demand on Molnupiravir nod
healthcare | Dec 29, 2021 10:41 AM IST
Molnupiravir unlikely to make big impact on Indian companies: Research Delta Advisors
healthcare | Dec 28, 2021 8:24 PM IST
Dr Reddy's Laboratories to introduce Molnupiravir to treat COVID-19 shortly
healthcare | Dec 28, 2021 5:04 PM IST
Experts' take on 'precautionary dose' and vaccine for kids
healthcare | Dec 28, 2021 9:26 AM IST
SEC grants EUA for anti-COVID pill Molnupiravir after application from 6 pharma firms
healthcare | Dec 2, 2021 2:59 PM IST
UK regulator approves GSK’s COVID antibody 'Xevudy' or 'Sotrovimab'

Molnupiravir NEWS

Don’t see opportunity for Paxlovid in EMs; no visibility on market size for Molnupiravir: Laurus Labs

Pfizer to share technology for COVID-19 antiviral drug, Paxlovid

Divi's Labs Q3 Earnings: Profit jumps 92% to Rs 902 crore, beats Street estimates

2 years on, vaccines, following protocols remain most effective weapons against COVID-19

Lupin launches Molnupiravir under brand 'Molnulup' for COVID treatment

How did Molnupiravir become a part of COVID treatment globally? Details here

COVID antiviral drug Molnupiravir has major safety concerns: ICMR chief

Dr Reddy's to launch Molflu at Rs 35 per capsule for COVID treatment

As COVID-19 antiviral Molnupiravir launches in India; here's all you need to know about the pill

Sun Pharma, Dr Reddy's, Divi's, other pharma stocks in high demand on Molnupiravir nod

Molnupiravir unlikely to make big impact on Indian companies: Research Delta Advisors

Dr Reddy's Laboratories to introduce Molnupiravir to treat COVID-19 shortly

Experts' take on 'precautionary dose' and vaccine for kids

SEC grants EUA for anti-COVID pill Molnupiravir after application from 6 pharma firms

UK regulator approves GSK’s COVID antibody 'Xevudy' or 'Sotrovimab'